Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Makmur Berkah Amanda Tbk (AMAN) vs Dharma Polimetal Tbk. (DRMA) Price & Performance

Makmur Berkah Amanda Tbk
Dharma Polimetal Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Makmur Berkah Amanda Tbk vs Dharma Polimetal Tbk. — how do they compare? Makmur Berkah Amanda Tbk trades at Rp256 (market cap 1.03T, 883.2K 24h volume), while Dharma Polimetal Tbk. trades at Rp900 (market cap 4.24T, 1.6M 24h volume). The key difference: Dharma Polimetal Tbk. is far larger — about 4.1× Makmur Berkah Amanda Tbk's market cap, and Dharma Polimetal Tbk. is more actively traded (1.6M versus 883.2K). Which is the better fit depends on your goals.

AMANDRMA
Market Cap
1.03T4.24T
Volume
883.2K1.6M
Lot
8.83K16.04K
Turnover
225.52M1.45B
Average Price
255.34901.1
Value
225.52M1.45B
Indicative Equilibrium Price
256900
Indicative Equilibrium Volume
11200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMAN
View details
DRMA
View details

About Makmur Berkah Amanda Tbk

PT Makmur Berkah Amanda Tbk (previously PT Sidomaju Industri Estate ("Company")) was established based on Deed No.224, dated May 31, 1996 made by Erly Soehandjojo, SH, notary in Jakarta and Notary Deed Number 5 dated July 2, 1997 made Soeharto, SH, notary in Sidoarjo (here in after referred to as " The Deed of Establishment Deed"). The Company has began its commercial operations since May 31, 1996.

Read more on AMAN

About Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Read more on DRMA